Effects of mood stabilizer on the circadian system: possible implication for abnormalities in mood disorders.
Ikeda
Masaaki
M
mikeda@saitama-med.ac.jp
D015720:5'-Nucleotidase / Q000502:physiology; D000818:Animals; D018692:Antimanic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001683:Biological Clocks / Q000235:genetics; D002220:Carbamazepine / Q000494:pharmacology / Q000627:therapeutic use; D002940:Circadian Rhythm / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D018020:Lithium Compounds / Q000494:pharmacology / Q000627:therapeutic use; D019964:Mood Disorders / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D012097:Repressor Proteins / Q000502:physiology; D014635:Valproic Acid / Q000494:pharmacology / Q000627:therapeutic use
D018692:Antimanic Agents; C514503:GSKIP protein, human; D018020:Lithium Compounds; D012097:Repressor Proteins; D002220:Carbamazepine; D014635:Valproic Acid; D015720:5'-Nucleotidase